Earlier this month, the United States Patent and Trademark Office (“PTO”) issued an update to its Interim Guidance on patent subject matter eligibility under 35 U.S.C. § 101.
On Wednesday, the FDA issued guidance on the use of the phrase “evaporated cane juice” in order to “enhance consumers’ ability to make informed choices among sweeteners by promoting accurate and consistent labeling.”
Jon Murray, a reporter for the Denver Post, had an article in Politico magazine salaciously titled The Marijuana Industry’s War on the Poor.
With the first summer holiday weekend set to begin with the end of the workday today, picnic baskets and grills are already on standby as people across America look forward to outdoor dining as part of their Memorial Day weekend activities.
J. Dannemiller Co. is recalling SunOpta 50# bags and 30# cases of roasted sunflower kernels roasted and salted, and sunflower kernels roasted no salt because they have the potential to be contaminated with Listeria.
This week, the U.S. House of Representatives unanimously passed the Fostering Innovation Act of 2015 (H.R. 4139), bipartisan legislation that would extend for an additional five years the current exemption for emerging growth companies from certain internal corporate financial control requirements of the Sarbanes-Oxley Act.
The Scope of FDA’s Proposed Revisions to the IND Regulations May Not Be Sufficient to Achieve Its Stated Goals
Last week, the U.S. Department of Health and Human Services (“HHS”) announced that FDA intends to update its regulations governing clinical studies of new drugs.
On May 17, the United States Court of Appeals for the Second Circuit affirmed the dismissal of a relator’s False Claims Act (FCA) claims predicated on allegations that Pfizer “improperly marketed Lipitor, a popular statin, as appropriate for patients whose risk factors and cholesterol levels fall outside the National Cholesterol Education Program (NCEP) Guidelines.”